Hepatitis B virus infection

Seminars in Fetal and Neonatal Medicine

Volumn 12, Issue 3, 2007, Pages 160-167

  Chang, Mei Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chronic hepatitis B; Hepatitis B e antigen; Hepatitis B immunoglogulin; Hepatitis B vaccine; Hepatitis B virus; Mother to infant transmission

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; PLACEBO;

CLINICAL TRIAL; DRUG EFFICACY; HEALTH CARE COST; HELPER CELL; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INCIDENCE; INFECTION CONTROL; LIVER CELL CARCINOMA; LIVER INJURY; NONHUMAN; PREGNANCY; PREVALENCE; RECOMMENDED DRUG DOSE; REVIEW; SEROCONVERSION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS;

EID: 34247569009     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2007.01.013     Document Type: Review

References (51)

1. Ganem D., and Prince A.M. Hepatitis B virus infection natural history and clinical consequences. N Engl J Med 350 (2004) 1118-1129
2. Hsu H.Y., Chang M.H., Chen D.S., Lee C.Y., and Sung J.L. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 18 (1986) 301-307
3. Feret E., Larouze B., Dip B., Sow M., London W.T., and Blumberg B.S. Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal. Am J Epidemiol 125 (1987) 140-149
4. Tiollais P., Pourcel C., and Dejean A. The hepatitis B virus. Nature 37 (1985) 489-495
5. Lau J.Y.N., and Wright T.L. Molecular virology and pathogenesis of hepatitis B. Lancet 342 (1993) 1335-1344
6. Stevens C.E., Beasley R.P., Tsui J., and Lee W.C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292 (1975) 771-774
7. Hsu S.C., Chang M.H., Ni Y.H., Hsu H.Y., and Lee C.Y. Horizontal transmission of HBV in children. J Pediatr Gastroenterol Nutr 16 (1993) 66-69
8. Hieber J.P., Dalton D., Shorey J., and Combes B. Hepatitis and pregnancy. J Pediatr 91 (1977) 545-549
9. Beasley R.P., Hwang L.Y., Lin C.C., Leu M.L., Steven C.E., Szmuness W., et al. Incidence of hepatitis B virus infection in preschool children in Taiwan. J Infect Dis 146 (1982) 198-204
10. Beasley R.P., Hwang L.Y., Lin C.C., Ko Y.C., and Twn S.J. Incidence of hepatitis among students at a university in Taiwan. Am J Epidemiol 117 (1983) 213-222
11. Tang J.R., Hsu H.Y., Lin H.H., Ni Y.H., and Chang M.H. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 133 (1998) 374-377
12. Lin H.H., Lee T.Y., Chen D.S., Suns J.L., Ohto H., Etoh T., et al. Transplacental leakage of HbeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 111 (1987) 877-881
13. Hsu H.Y., Chang M.H., Hsieh K.H., Lee C.Y., Li H.H., Hwang L.H., et al. Cellular immune response to hepatitis B core antigen in maternal infant transmission of hepatitis B virus. Hepatology 15 (1992) 770-776
14. Shiraki K., Yoshihara N., Sakurai M., Eto T., and Kawana T. Acute hepatitis B in infants born to carrier mothers with the antibody to hepatitis B e antigen. J Pediatr 97 (1980) 768-770
15. Chen H.L., Chang C.J., Kong M.S., Huang F.C., Lee H.C., Lin C.C., et al. Fulminant hepatic failure in children in endemic area of hepatitis B virus infection: 15 years after universal hepatitis B vaccination. Hepatology 39 (2004) 58-63
16. Chang M.H., Lee C.Y., Chen D.S., Hsu H.C., and Lai M.Y. Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr 111 (1987) 34-39
17. Bortolotti F., Cadrobbi P., Crivellaro C., Guido M., Rugge M., Noventa F., et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus in infection in childhood. Gastroenterology 99 (1990) 805-810
18. Chang M.H., Sung J.L., Lee C.Y., Chen J.S., Hsu H.Y., Lee P.I., et al. Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr 115 (1989) 385-390
19. Bortolotti F., Wirth S., Crivellaro C., Alberti A., Martine U., and de Moliner L. Long-term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion. J Pediatr Gastroenterol Nutr 22 (1996) 270-274
20. Bortolotti F., Cadrobbi M., Crivellaro C., Guido M., Rugge M., Noventa F., et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 99 (1990) 805-810
21. Bortolotti F., Cuido M., Bartolacci S., Cadrobbi P., Crivellaro C., Noventa F., et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 43 (2006) 556-562
22. Chang M.H., Hsu H.Y., Hsu H.C., Ni Y.H., Chen J.S., and Chen D.S. The significance of spontaneous HBeAg seroconversion in childhood: with special emphasis on the clearance of HBeAg before three years of age. Hepatology 22 (1995) 1387-1392
23. Wen W.H., Chang M.H., Hsu H.Y., Ni Y.H., and Chen H.L. The development of hepatocellular carcinoma among 426 prospectively followed children with chronic hepatitis B virus infection. J Pediatr 144 (2004) 397-399
24. Chang M.H., Chen D.S., Hsu H.C., Hsu H.Y., and Lee C.Y. Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma. Cancer 64 (1989) 2377-2380
25. Ni Y.H., Chang M.H., Wang K.J., Hsu H.Y., Chen H.L., Kao J.H., et al. Clinical relevance of hepatitis B virus genotype in children with chronic hepatitis B and hepatocellular carcinoma. Gastroenterology 127 (2004) 1733-1738
26. Hsu N.H.M., Chen D.S., Chuang C.H., Lu J.C., Jwo D.M., Lee C.C., et al. Efficacy of a mass hepatitis B vaccination program in Taiwan: studies on 3464 infants of hepatitis B surface antigen-carrier mothers. J Am Med Assoc 260 (1988) 2231-2235
27. Shepard C.W., Simard E.P., Finelli L., Fiore A.F., and Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28 (2006) 112-125
28. Poovorawan Y., Theamboonlers A., Vimolket T., Sinlaparatsamee S., Chaiear K., Siraprapasiri T., et al. Impact of hepatitis B immunization as part of the EPI. Vaccine 19 (2000) 943-949
29. WHO. Report on the Expanded Program on Immunization (EPI) of the World Health Organisation (WHO) Department of Vaccines and Biologicals. (Post-exposure immunization for hepatitis B). Geneva: WHO; www.who.immunization/.
30. Chen H.L., Chang M.H., Ni Y.H., Hsu H.Y., Lee P.I., Chen D.S., et al. Seroepidemiology of hepatitis B virus infection in children - ten years of mass vaccination in Taiwan. J Am Med Assoc 276 (1996) 906-908
31. Ni Y.H., Chang M.H., Huang L.M., Chen H.L., Hsu H.Y., Chiu T.Y., et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135 (2001) 796-800
32. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336 (1997) 1855-1859
33. Chang M.H., Chen J., Hsu H.M., Wu T.C., Kong M.S., Liang D.C., et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 11 (2005) 7953-7957
34. Kao J.H., Hsu H.M., Shau W.Y., Chang M.H., and Chen D.S. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 139 (2001) 349-352
35. Hsu H.Y., Chang M.H., Ni Y.H., and Chen H.L. Survey of hepatitis B surface variant infection in children 15 years after nationwide vaccination program in Taiwan. Gut 53 (2004) 1499-1503
36. Hsu H.Y., Chang M.H., Liaw S.H., Ni Y.H., and Chen H.L. Changes of hepatitis B surface variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30 (1999) 1312-1317
37. Liaw Y.F., Leung N., Guan R., Lau G.K.K., Merican I., McCaughan G., et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int 25 (2005) 472-489
38. Van Zonneveld M., van Nunen A.B., Niesters H.G.M., de Man R.A., Schalm S.W., and Janssen H.L.A. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepatitis 10 (2003) 294-297
39. Xu W.M., Cui Y.T., Wang L., Yang H., Liang Z.Q., Li X.M., et al. Efficacy and safety of lamivudine in late pregnancy for the prevention of mother-child transmission of hepatitis B: a multicentre, randomized, double-blind, placebo-controlled study. Hepatology 40 (2004) 272A [abstract 246]
40. Torre D., and Tambini R. Interferon alfa-2a therapy for chronic hepatitis B in children: a meta-analysis. Clin Infect Dis 23 (1996) 131-137
41. Lai C.L., Lok A.S.F., Lin H.J., Wu P.C., Yeoh E.K., and Yeung C.Y. Placebo-controlled trial of recombinant α2-interferon in Chinese HBsAg-carrier children. Lancet 17 (1987) 877-880
42. Barbera C., Bortolotti F., Crivellaro C., Coscia A., Zancan L., Cadrobbi P., et al. Recombinant interferon-2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology 20 (1994) 287-290
43. Ruiz-Moreno M., Camps T., Jimenez J., López R., Castillo I., Bartolomé J., et al. Factors predictive of response to interferon therapy in children with chronic hepatitis B. J Hepatol 22 (1995) 540-544
44. Gregorio G.V., Jara P., Hierro L., Diaz C., Vega A.de.la., Vegnente A., et al. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial. Hepatology 23 (1996) 700-707
45. Vajro P., Tedesco M., Fontanella A., De Vincenzo A., Raffaella V., Ammendola R., et al. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection. Pediatr Infect Dis J 15 (1996) 223-231
46. Sokal E.M., Conjeevaram H.S., Roberts E.A., Alvarez F., Bern E.M., Goyens P., et al. Interferon alpha therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology 114 (1998) 988-995
47. Torre D., and Tambini R. Interferon-α therapy for chronic hepatitis B in children: a meta-analysis. Clin Infect Dis 23 (1996) 131-137
48. Bortolotti F., Jara P., Barbera C., Ramos J., Perney P., Laurent C., et al. Long term effect of alpha interferon in children with chronic hepatitis B. Gut 46 (2000) 715-718
49. Jonas M., Kelly P., Mizerski J., Badia I.B., Areias J.A., Schwarz K.B., et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 346 (2002) 1706-1713
50. Sokal E.M., Kelly D.A., Badia I.B., Badia I.B., Areias J.A., Schwarz K.B., et al. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 43 (2006) 225-232
51. Zoulin F., and Trepo C. Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. J Hepatol 29 (1998) 151-168